Blog/FDA Releases Guidance on Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers
FDA Releases Guidance on Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers
Oct 8, 2024
In October 2024, the U.S. Food and Drug Administration issued a final guidance titled Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers. https://www.fda.gov/media/166215/download
This guidance provides recommendations on the use of electronic systems, electronic records and electronic signatures in food, medical product, tobacco product, and new animal drug clinical investigations.
This guidance finalizes the draft guidance for industry issued in March 2023, titled Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 CFR Part 11–Questions and Answers.
Flex Databases has analyzed the guidance and is ready to share how we support our Clients being the trusted software development vendor.
Regulated entities are responsible for ensuring that electronic records meet applicable part 11 requirements. When determining the suitability of the IT service and IT service provider, regulated entities should consider the following regarding the IT service provider’s ability to ensure the authenticity, integrity, and confidentiality of clinical investigation records and data:
FDA requirement
Flex Databases guarantees
Processes and procedures the IT service provider has in place for validation of specific IT services to be used in the clinical investigation
Fully validated system with the validation deliverables package Support during User Acceptance Testing
Ability of the IT service provider to generate accurate and complete copies of records and to provide access to data for as long as the records are required to be retained by applicable regulations
Retention period is negotiated and captured in the contract. All the data stored in the system is subject to full backup and is stored as long as required.
Processes and procedures the IT service provider has for data migration, data backup, recovery, contingency plans, and retaining records and making them available for FDA inspection for as long as the records are required to be retained by applicable regulations
Always ready to share our SOPs, including the backup procedure, Disaster Recovery and Business Continuity Plans and Reports, data migration working practice and relevant deliverables
Ability to provide secure, computer-generated, time-stamped audit trails of users’ actions and changes to data
Audit trail captures all actions performed in the system
Ability to secure and protect the confidentiality of data at rest and in transit (as appropriate for the content and nature of the record)
All traffic into and out of the Flex Databases Platform is encrypted, all backups are encrypted-in-transit to the separate data center and are encrypted-at-rest while stored at that location.
Blog
Oct 8, 2024
FDA Releases Guidance on Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers
In October 2024, the U.S. Food and Drug Administration issued a final guidance titled Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers. https://www.fda.gov/media/166215/download This guidance provides recommendations on the use of electronic systems, electronic records and electronic signatures in food, medical product, tobacco product, and new animal drug clinical investigations. […]
Client Spotlight: FGK Clinical Research GmbH CRO’s Experience with Flex Database
We had the pleasure of sitting down with Martin Krauss, Co-Founder and Managing Director of FGK CRO, to discuss how Flex Databases has supported their clinical research operations over the past 3.5 years.In this interview, Martin shares: • Why FGK CRO initially chose to partner with Flex Databases.• How our CTMS, TMF, and LMS solutions have transformed […]
We are thrilled to share several key enhancements that will streamline your workflows and improve data management. Enhanced Duplicates Search Our Duplicates Search feature has received a significant upgrade! The system now identifies 100% duplicate files from your Inbox by checksum, ensuring cleaner data management. When files are moved from the Inbox to any folder […]
Cloud-based CTMS vs. On-premises CTMS: Which is Right for Your Clinical Trial Management?
Two popular models dominate the Clinical Trial management System landscape: Cloud-based and On-premises CTMS. Both have their merits, but choosing the right option depends on several factors, including cost, scalability, security, and operational requirements. This article will explore the differences between Cloud-based Clinical Trial Management System and on-premises CTMS, helping you determine which solution best […]
Get in touch to discuss compliance, implementation, demos, pricing
We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.
Thank you for your interest.
Thank you for your interest. We are working on your request and will come back to you in the next 24 hours.
